Join our teams!
We do everything possible for all Group employees to have the means to succeed, to adapt, to take on responsibilities and to grow. At Servier, you will be offered a unique and meaningful professional experience.
Home - Servier
Our latest news
22000
Employees in 66 countries,
including 5,000 in France.
100 million
patients treated each day worldwide with Servier medicines.
25 %
of revenue from brand-name medicines invested in R&D each year on average.
€ 4.6 billion
euros in revenue in 2018/2019 comprising €3.2 billion for brand-name medicines and €1.4 billion for generic medicines.
5 therapeutic areas
cardiovascular, cancer, diabetes immune-inflammatory and neuropsychiatric diseases.
R&D: To accelerate therapeutic innovation
To discover new treatments that improve patients’ lives, the Group focuses its research and development efforts in therapeutic areas where needs are substantial.
Our Group’s corporate social responsibility
The Mécénat Servier Charity Fund is one of the main aims of our CSR strategy, and a natural extension of our commitment to therapeutic progress to serve patient needs.
The basis for our actions
Because passing on to future generations a world that can ensure access to quality health care for all is our vision for the future, at Servier, all over the world, we are ready to meet the health care challenges of tomorrow, for and with patients. Discover our corporate video.
